Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.
about
Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enhancing siRNA-based cancer t ...... ide-modified liposomal system.
@en
Enhancing siRNA-based cancer t ...... ide-modified liposomal system.
@nl
type
label
Enhancing siRNA-based cancer t ...... ide-modified liposomal system.
@en
Enhancing siRNA-based cancer t ...... ide-modified liposomal system.
@nl
prefLabel
Enhancing siRNA-based cancer t ...... ide-modified liposomal system.
@en
Enhancing siRNA-based cancer t ...... ide-modified liposomal system.
@nl
P2093
P2860
P356
P1476
Enhancing siRNA-based cancer t ...... ide-modified liposomal system.
@en
P2093
De-Ying Cao
Jin-Long Qi
Li-Ping Yang
Shao-Kun Yang
Wei-Hong Sun
Xian-Rong Qi
Xue-Li Jia
P2860
P304
P356
10.2147/IJN.S129574
P407
P577
2017-03-28T00:00:00Z